Beijing, China

Meng Hao

This inventor holds 1 USPTO granted patent. Top assignee: Academy of Military Medical Science, Pla. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meng Hao. Retrieved from https://idiyas.com/inventor/meng-hao-sns3o71r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Meng Hao

Introduction

Meng Hao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the development of monoclonal antibodies. His work is vital for advancing treatments against various viral infections.

Latest Patents

Meng Hao holds a patent for "Monoclonal Antibodies Against Henipavirus Glycoprotein G and Encoding Nucleic Acids Thereof." This innovative patent addresses critical aspects of viral research and has the potential to impact therapeutic strategies.

Career Highlights

Meng Hao is affiliated with the Academy of Military Medical Science, PLA. His role in this esteemed institution allows him to collaborate with leading experts in the field. His dedication to research and innovation has earned him recognition in the scientific community.

Collaborations

Meng Hao has worked alongside notable colleagues such as Wei Chen and Changming Yu. Their combined expertise fosters a collaborative environment that enhances the quality of their research.

Conclusion

Meng Hao's contributions to medical science through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for advancements in viral research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…